Has David Turok received payments from drug or device companies?

Yes. Drug and device makers reported $968,280 in general payments to David Turok across 37 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Turok did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Turok come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Turok

Obstetrics & Gynecology · Salt Lake City, UTNPI 1568449379

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $608,510 of the $968,280 with a category attached, or 62.8%. 7 manufacturers reported payments, led by Sebela Women's Health Inc. at 46.4% of the total. Reporting peaked in 2021 at $454,823 and has fallen 78.1% since, to $99,756 in 2025. Among obstetrics & gynecology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$968,280in general payments, 2019–2025

Across 37 payments — averaging $26,170 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sebela Women's Health Inc.$449K
Coopersurgical, Inc.$358K
Sebela Pharmaceuticals Inc.$160K
Sumitomo Pharma America, Inc.$1K
Bayer$97
Merck$59
plus $14 from 1 others

$2,431,496in research payments, 2019–2025

Across 36 payments — averaging $67,542 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$1.5M
Organon$760K
Medicines360$157K
Sebela Pharmaceuticals Inc.$20K
Sumitomo Pharma America, Inc.$7K

What the payments were for

Consulting fees$608,51063%
Grants$358,17637%
Travel & lodging$1,0420%
Food & beverage$5520%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sebela Women's Health Inc.	17	$448,901
Coopersurgical, Inc.	6	$358,176
Sebela Pharmaceuticals Inc.	4	$159,609
Sumitomo Pharma America, Inc.	4	$1,425
Bayer	4	$97
Merck	1	$59
AbbVie	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Paragard$358,176
MYFEMBREE$1,425

How this compares

$968,280 in reported general payments places this provider in the 95th percentile of 294 obstetrics & gynecology providers in Utah.

See all obstetrics & gynecology providers in Utah →

Other obstetrics & gynecology in Salt Lake City

Jennifer KinghornSalt Lake City$15K
Alan RappleyeSalt Lake City$14K
Azadeh PoursaidSalt Lake City$14K
Stewart BarlowSalt Lake City$10K
Jason JohnsonSalt Lake City$9K
Caleb HopwoodSalt Lake City$8K
Marisa AdelmanSalt Lake City$7K
David BranchSalt Lake City$6K
Kathryn ArbabiSalt Lake City$6K
Kristen LiljaSalt Lake City$5K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →